Extracorporeal Liver Assist Device (Elad) Market Report

Japan Extracorporeal Liver Assist Device (Elad) Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • POSTDATE：Sep 15, 2019
  • PAGES：211
  • REPORT CODE：GMM233886
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Extracorporeal Liver Assist Device (Elad) market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Extracorporeal Liver Assist Device (Elad) market. Detailed analysis of key players, along with key growth strategies adopted by Extracorporeal Liver Assist Device (Elad) industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.


    By Player:

    • Thoratec Corp. (USA)

    • Baxter International, Inc. (USA)

    • Nikkiso Co., Ltd. (Japan)

    • Abbott Diabetes Care, Inc. (USA)

    • Fresenius Medical Care AG & Co. KGaA (Germany)

    • Terumo Heart, Inc (USA)

    • SynCardia Systems, Inc. (USA)

    • HeartWare International, Inc. (USA)

    • Toray Medical Co., Ltd. (Japan)

    • Medtronic, Inc. (USA)

    • Vital Therapies, Inc. (USA)

    • Terumo Heart, Inc. (USA)

    • Abbott Diabetes Care, Inc (USA)

    • Asahi Kasei Medical Co., Ltd. (Japan)


    By Type:

    • Type 1

    • Type 2

    • Type 3


    By End-User:

    • End-Users 1

    • End-Users 2

    • End-Users 3


    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Extracorporeal Liver Assist Device (Elad) Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Extracorporeal Liver Assist Device (Elad) Market Size and Growth Rate of Type 1 from 2014 to 2026

      • 1.3.2 Japan Extracorporeal Liver Assist Device (Elad) Market Size and Growth Rate of Type 2 from 2014 to 2026

      • 1.3.3 Japan Extracorporeal Liver Assist Device (Elad) Market Size and Growth Rate of Type 3 from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Extracorporeal Liver Assist Device (Elad) Market Size and Growth Rate of Application 1 from 2014 to 2026

      • 1.4.2 Japan Extracorporeal Liver Assist Device (Elad) Market Size and Growth Rate of Application 2 from 2014 to 2026

      • 1.4.3 Japan Extracorporeal Liver Assist Device (Elad) Market Size and Growth Rate of Application 3 from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Extracorporeal Liver Assist Device (Elad) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Extracorporeal Liver Assist Device (Elad) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Extracorporeal Liver Assist Device (Elad) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Extracorporeal Liver Assist Device (Elad) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Extracorporeal Liver Assist Device (Elad) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Extracorporeal Liver Assist Device (Elad) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Extracorporeal Liver Assist Device (Elad) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Extracorporeal Liver Assist Device (Elad) Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Extracorporeal Liver Assist Device (Elad) Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Extracorporeal Liver Assist Device (Elad) by Major Types

      • 3.4.1 Market Size and Growth Rate of Type 1

      • 3.4.2 Market Size and Growth Rate of Type 2

      • 3.4.3 Market Size and Growth Rate of Type 3

    4 Segmentation of Extracorporeal Liver Assist Device (Elad) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Extracorporeal Liver Assist Device (Elad) by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Extracorporeal Liver Assist Device (Elad) in Application 1

      • 4.4.2 Market Size and Growth Rate of Extracorporeal Liver Assist Device (Elad) in Application 2

      • 4.4.3 Market Size and Growth Rate of Extracorporeal Liver Assist Device (Elad) in Application 3


    5 Market Analysis by Regions

    • 5.1 Japan Extracorporeal Liver Assist Device (Elad) Production Analysis by Regions

    • 5.2 Japan Extracorporeal Liver Assist Device (Elad) Consumption Analysis by Regions


    6 Hokkaido Extracorporeal Liver Assist Device (Elad) Landscape Analysis

    • 6.1 Hokkaido Extracorporeal Liver Assist Device (Elad) Landscape Analysis by Major Types

    • 6.2 Hokkaido Extracorporeal Liver Assist Device (Elad) Landscape Analysis by Major End-Users


    7 Tohoku Extracorporeal Liver Assist Device (Elad) Landscape Analysis

    • 7.1 Tohoku Extracorporeal Liver Assist Device (Elad) Landscape Analysis by Major Types

    • 7.2 Tohoku Extracorporeal Liver Assist Device (Elad) Landscape Analysis by Major End-Users


    8 Kanto Extracorporeal Liver Assist Device (Elad) Landscape Analysis

    • 8.1 Kanto Extracorporeal Liver Assist Device (Elad) Landscape Analysis by Major Types

    • 8.2 Kanto Extracorporeal Liver Assist Device (Elad) Landscape Analysis by Major End-Users


    9 Chubu Extracorporeal Liver Assist Device (Elad) Landscape Analysis

    • 9.1 Chubu Extracorporeal Liver Assist Device (Elad) Landscape Analysis by Major Types

    • 9.2 Chubu Extracorporeal Liver Assist Device (Elad) Landscape Analysis by Major End-Users


    10 Kinki Extracorporeal Liver Assist Device (Elad) Landscape Analysis

    • 10.1 Kinki Extracorporeal Liver Assist Device (Elad) Landscape Analysis by Major Types

    • 10.2 Kinki Extracorporeal Liver Assist Device (Elad) Landscape Analysis by Major End-Users


    11 Chugoku Extracorporeal Liver Assist Device (Elad) Landscape Analysis

    • 11.1 Chugoku Extracorporeal Liver Assist Device (Elad) Landscape Analysis by Major Types

    • 11.2 Chugoku Extracorporeal Liver Assist Device (Elad) Landscape Analysis by Major End-Users


    12 Shikoku Extracorporeal Liver Assist Device (Elad) Landscape Analysis

    • 12.1 Shikoku Extracorporeal Liver Assist Device (Elad) Landscape Analysis by Major Types

    • 12.2 Shikoku Extracorporeal Liver Assist Device (Elad) Landscape Analysis by Major End-Users


    13 Kyushu Extracorporeal Liver Assist Device (Elad) Landscape Analysis

    • 13.1 Kyushu Extracorporeal Liver Assist Device (Elad) Landscape Analysis by Major Types

    • 13.2 Kyushu Extracorporeal Liver Assist Device (Elad) Landscape Analysis by Major End-Users


    14 Major Players Profiles

    • 14.1 Thoratec Corp. (USA)

      • 14.1.1 Thoratec Corp. (USA) Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Baxter International, Inc. (USA)

      • 14.2.1 Baxter International, Inc. (USA) Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 Nikkiso Co., Ltd. (Japan)

      • 14.3.1 Nikkiso Co., Ltd. (Japan) Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 Abbott Diabetes Care, Inc. (USA)

      • 14.4.1 Abbott Diabetes Care, Inc. (USA) Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Fresenius Medical Care AG & Co. KGaA (Germany)

      • 14.5.1 Fresenius Medical Care AG & Co. KGaA (Germany) Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 Terumo Heart, Inc (USA)

      • 14.6.1 Terumo Heart, Inc (USA) Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 SynCardia Systems, Inc. (USA)

      • 14.7.1 SynCardia Systems, Inc. (USA) Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 HeartWare International, Inc. (USA)

      • 14.8.1 HeartWare International, Inc. (USA) Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

    • 14.9 Toray Medical Co., Ltd. (Japan)

      • 14.9.1 Toray Medical Co., Ltd. (Japan) Company Profile and Recent Development

      • 14.9.2 Market Performance

      • 14.9.3 Product and Service Introduction

    • 14.10 Medtronic, Inc. (USA)

      • 14.10.1 Medtronic, Inc. (USA) Company Profile and Recent Development

      • 14.10.2 Market Performance

      • 14.10.3 Product and Service Introduction

    • 14.11 Vital Therapies, Inc. (USA)

      • 14.11.1 Vital Therapies, Inc. (USA) Company Profile and Recent Development

      • 14.11.2 Market Performance

      • 14.11.3 Product and Service Introduction

    • 14.12 Terumo Heart, Inc. (USA)

      • 14.12.1 Terumo Heart, Inc. (USA) Company Profile and Recent Development

      • 14.12.2 Market Performance

      • 14.12.3 Product and Service Introduction

    • 14.13 Abbott Diabetes Care, Inc (USA)

      • 14.13.1 Abbott Diabetes Care, Inc (USA) Company Profile and Recent Development

      • 14.13.2 Market Performance

      • 14.13.3 Product and Service Introduction

    • 14.14 Asahi Kasei Medical Co., Ltd. (Japan)

      • 14.14.1 Asahi Kasei Medical Co., Ltd. (Japan) Company Profile and Recent Development

      • 14.14.2 Market Performance

      • 14.14.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 131 Figures and 169 Tables)

     

    • Figure Japan Extracorporeal Liver Assist Device (Elad) Market Size and Growth Rate of Type 1 from 2014 to 2026

    • Figure Japan Extracorporeal Liver Assist Device (Elad) Market Size and Growth Rate of Type 2 from 2014 to 2026

    • Figure Japan Extracorporeal Liver Assist Device (Elad) Market Size and Growth Rate of Type 3 from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Extracorporeal Liver Assist Device (Elad) Market Size and Growth Rate of Application 1 from 2014 to 2026

    • Figure Japan Extracorporeal Liver Assist Device (Elad) Market Size and Growth Rate of Application 2 from 2014 to 2026

    • Figure Japan Extracorporeal Liver Assist Device (Elad) Market Size and Growth Rate of Application 3 from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Extracorporeal Liver Assist Device (Elad) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Extracorporeal Liver Assist Device (Elad) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Extracorporeal Liver Assist Device (Elad) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Extracorporeal Liver Assist Device (Elad) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Extracorporeal Liver Assist Device (Elad) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Extracorporeal Liver Assist Device (Elad) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Extracorporeal Liver Assist Device (Elad) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Extracorporeal Liver Assist Device (Elad) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Extracorporeal Liver Assist Device (Elad) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Extracorporeal Liver Assist Device (Elad)

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Extracorporeal Liver Assist Device (Elad) by Different Types from 2014 to 2026

    • Table Consumption Share of Extracorporeal Liver Assist Device (Elad) by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Type 1

    • Figure Market Size and Growth Rate of Type 2

    • Figure Market Size and Growth Rate of Type 3

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Extracorporeal Liver Assist Device (Elad) by Different End-Users from 2014 to 2026

    • Table Consumption Share of Extracorporeal Liver Assist Device (Elad) by Different End-Users from 2014 to 2026

    • Figure Japan Extracorporeal Liver Assist Device (Elad) Market Size and Growth Rate of Application 1 from 2014 to 2026

    • Figure Japan Extracorporeal Liver Assist Device (Elad) Market Size and Growth Rate of Application 2 from 2014 to 2026

    • Figure Japan Extracorporeal Liver Assist Device (Elad) Market Size and Growth Rate of Application 3 from 2014 to 2026

    • Table Japan Extracorporeal Liver Assist Device (Elad) Production by Regions

    • Table Japan Extracorporeal Liver Assist Device (Elad) Production Share by Regions

    • Figure Japan Extracorporeal Liver Assist Device (Elad) Production Share by Regions in 2014

    • Figure Japan Extracorporeal Liver Assist Device (Elad) Production Share by Regions in 2018

    • Figure Japan Extracorporeal Liver Assist Device (Elad) Production Share by Regions in 2026

    • Table Japan Extracorporeal Liver Assist Device (Elad) Consumption by Regions

    • Table Japan Extracorporeal Liver Assist Device (Elad) Consumption Share by Regions

    • Figure Japan Extracorporeal Liver Assist Device (Elad) Consumption Share by Regions in 2014

    • Figure Japan Extracorporeal Liver Assist Device (Elad) Consumption Share by Regions in 2018

    • Figure Japan Extracorporeal Liver Assist Device (Elad) Consumption Share by Regions in 2026

    • Table Hokkaido Extracorporeal Liver Assist Device (Elad) Consumption by Types from 2014 to 2026

    • Table Hokkaido Extracorporeal Liver Assist Device (Elad) Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Extracorporeal Liver Assist Device (Elad) Consumption Share by Types in 2014

    • Figure Hokkaido Extracorporeal Liver Assist Device (Elad) Consumption Share by Types in 2018

    • Figure Hokkaido Extracorporeal Liver Assist Device (Elad) Consumption Share by Types in 2026

    • Table Hokkaido Extracorporeal Liver Assist Device (Elad) Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Extracorporeal Liver Assist Device (Elad) Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Extracorporeal Liver Assist Device (Elad) Consumption Share by End-Users in 2014

    • Figure Hokkaido Extracorporeal Liver Assist Device (Elad) Consumption Share by End-Users in 2018

    • Figure Hokkaido Extracorporeal Liver Assist Device (Elad) Consumption Share by End-Users in 2026

    • Table Tohoku Extracorporeal Liver Assist Device (Elad) Consumption by Types from 2014 to 2026

    • Table Tohoku Extracorporeal Liver Assist Device (Elad) Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Extracorporeal Liver Assist Device (Elad) Consumption Share by Types in 2014

    • Figure Tohoku Extracorporeal Liver Assist Device (Elad) Consumption Share by Types in 2018

    • Figure Tohoku Extracorporeal Liver Assist Device (Elad) Consumption Share by Types in 2026

    • Table Tohoku Extracorporeal Liver Assist Device (Elad) Consumption by End-Users from 2014 to 2026

    • Table Tohoku Extracorporeal Liver Assist Device (Elad) Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Extracorporeal Liver Assist Device (Elad) Consumption Share by End-Users in 2014

    • Figure Tohoku Extracorporeal Liver Assist Device (Elad) Consumption Share by End-Users in 2018

    • Figure Tohoku Extracorporeal Liver Assist Device (Elad) Consumption Share by End-Users in 2026

    • Table Kanto Extracorporeal Liver Assist Device (Elad) Consumption by Types from 2014 to 2026

    • Table Kanto Extracorporeal Liver Assist Device (Elad) Consumption Share by Types from 2014 to 2026

    • Figure Kanto Extracorporeal Liver Assist Device (Elad) Consumption Share by Types in 2014

    • Figure Kanto Extracorporeal Liver Assist Device (Elad) Consumption Share by Types in 2018

    • Figure Kanto Extracorporeal Liver Assist Device (Elad) Consumption Share by Types in 2026

    • Table Kanto Extracorporeal Liver Assist Device (Elad) Consumption by End-Users from 2014 to 2026

    • Table Kanto Extracorporeal Liver Assist Device (Elad) Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Extracorporeal Liver Assist Device (Elad) Consumption Share by End-Users in 2014

    • Figure Kanto Extracorporeal Liver Assist Device (Elad) Consumption Share by End-Users in 2018

    • Figure Kanto Extracorporeal Liver Assist Device (Elad) Consumption Share by End-Users in 2026

    • Table Chubu Extracorporeal Liver Assist Device (Elad) Consumption by Types from 2014 to 2026

    • Table Chubu Extracorporeal Liver Assist Device (Elad) Consumption Share by Types from 2014 to 2026

    • Figure Chubu Extracorporeal Liver Assist Device (Elad) Consumption Share by Types in 2014

    • Figure Chubu Extracorporeal Liver Assist Device (Elad) Consumption Share by Types in 2018

    • Figure Chubu Extracorporeal Liver Assist Device (Elad) Consumption Share by Types in 2026

    • Table Chubu Extracorporeal Liver Assist Device (Elad) Consumption by End-Users from 2014 to 2026

    • Table Chubu Extracorporeal Liver Assist Device (Elad) Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Extracorporeal Liver Assist Device (Elad) Consumption Share by End-Users in 2014

    • Figure Chubu Extracorporeal Liver Assist Device (Elad) Consumption Share by End-Users in 2018

    • Figure Chubu Extracorporeal Liver Assist Device (Elad) Consumption Share by End-Users in 2026

    • Table Kinki Extracorporeal Liver Assist Device (Elad) Consumption by Types from 2014 to 2026

    • Table Kinki Extracorporeal Liver Assist Device (Elad) Consumption Share by Types from 2014 to 2026

    • Figure Kinki Extracorporeal Liver Assist Device (Elad) Consumption Share by Types in 2014

    • Figure Kinki Extracorporeal Liver Assist Device (Elad) Consumption Share by Types in 2018

    • Figure Kinki Extracorporeal Liver Assist Device (Elad) Consumption Share by Types in 2026

    • Table Kinki Extracorporeal Liver Assist Device (Elad) Consumption by End-Users from 2014 to 2026

    • Table Kinki Extracorporeal Liver Assist Device (Elad) Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Extracorporeal Liver Assist Device (Elad) Consumption Share by End-Users in 2014

    • Figure Kinki Extracorporeal Liver Assist Device (Elad) Consumption Share by End-Users in 2018

    • Figure Kinki Extracorporeal Liver Assist Device (Elad) Consumption Share by End-Users in 2026

    • Table Chugoku Extracorporeal Liver Assist Device (Elad) Consumption by Types from 2014 to 2026

    • Table Chugoku Extracorporeal Liver Assist Device (Elad) Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Extracorporeal Liver Assist Device (Elad) Consumption Share by Types in 2014

    • Figure Chugoku Extracorporeal Liver Assist Device (Elad) Consumption Share by Types in 2018

    • Figure Chugoku Extracorporeal Liver Assist Device (Elad) Consumption Share by Types in 2026

    • Table Chugoku Extracorporeal Liver Assist Device (Elad) Consumption by End-Users from 2014 to 2026

    • Table Chugoku Extracorporeal Liver Assist Device (Elad) Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Extracorporeal Liver Assist Device (Elad) Consumption Share by End-Users in 2014

    • Figure Chugoku Extracorporeal Liver Assist Device (Elad) Consumption Share by End-Users in 2018

    • Figure Chugoku Extracorporeal Liver Assist Device (Elad) Consumption Share by End-Users in 2026

    • Table Shikoku Extracorporeal Liver Assist Device (Elad) Consumption by Types from 2014 to 2026

    • Table Shikoku Extracorporeal Liver Assist Device (Elad) Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Extracorporeal Liver Assist Device (Elad) Consumption Share by Types in 2014

    • Figure Shikoku Extracorporeal Liver Assist Device (Elad) Consumption Share by Types in 2018

    • Figure Shikoku Extracorporeal Liver Assist Device (Elad) Consumption Share by Types in 2026

    • Table Shikoku Extracorporeal Liver Assist Device (Elad) Consumption by End-Users from 2014 to 2026

    • Table Shikoku Extracorporeal Liver Assist Device (Elad) Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Extracorporeal Liver Assist Device (Elad) Consumption Share by End-Users in 2014

    • Figure Shikoku Extracorporeal Liver Assist Device (Elad) Consumption Share by End-Users in 2018

    • Figure Shikoku Extracorporeal Liver Assist Device (Elad) Consumption Share by End-Users in 2026

    • Table Kyushu Extracorporeal Liver Assist Device (Elad) Consumption by Types from 2014 to 2026

    • Table Kyushu Extracorporeal Liver Assist Device (Elad) Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Extracorporeal Liver Assist Device (Elad) Consumption Share by Types in 2014

    • Figure Kyushu Extracorporeal Liver Assist Device (Elad) Consumption Share by Types in 2018

    • Figure Kyushu Extracorporeal Liver Assist Device (Elad) Consumption Share by Types in 2026

    • Table Kyushu Extracorporeal Liver Assist Device (Elad) Consumption by End-Users from 2014 to 2026

    • Table Kyushu Extracorporeal Liver Assist Device (Elad) Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Extracorporeal Liver Assist Device (Elad) Consumption Share by End-Users in 2014

    • Figure Kyushu Extracorporeal Liver Assist Device (Elad) Consumption Share by End-Users in 2018

    • Figure Kyushu Extracorporeal Liver Assist Device (Elad) Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Thoratec Corp. (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Thoratec Corp. (USA)

    • Figure Sales and Growth Rate Analysis of Thoratec Corp. (USA)

    • Figure Revenue and Market Share Analysis of Thoratec Corp. (USA)

    • Table Product and Service Introduction of Thoratec Corp. (USA)

    • Table Company Profile and Development Status of Baxter International, Inc. (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Baxter International, Inc. (USA)

    • Figure Sales and Growth Rate Analysis of Baxter International, Inc. (USA)

    • Figure Revenue and Market Share Analysis of Baxter International, Inc. (USA)

    • Table Product and Service Introduction of Baxter International, Inc. (USA)

    • Table Company Profile and Development Status of Nikkiso Co., Ltd. (Japan)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nikkiso Co., Ltd. (Japan)

    • Figure Sales and Growth Rate Analysis of Nikkiso Co., Ltd. (Japan)

    • Figure Revenue and Market Share Analysis of Nikkiso Co., Ltd. (Japan)

    • Table Product and Service Introduction of Nikkiso Co., Ltd. (Japan)

    • Table Company Profile and Development Status of Abbott Diabetes Care, Inc. (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Diabetes Care, Inc. (USA)

    • Figure Sales and Growth Rate Analysis of Abbott Diabetes Care, Inc. (USA)

    • Figure Revenue and Market Share Analysis of Abbott Diabetes Care, Inc. (USA)

    • Table Product and Service Introduction of Abbott Diabetes Care, Inc. (USA)

    • Table Company Profile and Development Status of Fresenius Medical Care AG & Co. KGaA (Germany)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Fresenius Medical Care AG & Co. KGaA (Germany)

    • Figure Sales and Growth Rate Analysis of Fresenius Medical Care AG & Co. KGaA (Germany)

    • Figure Revenue and Market Share Analysis of Fresenius Medical Care AG & Co. KGaA (Germany)

    • Table Product and Service Introduction of Fresenius Medical Care AG & Co. KGaA (Germany)

    • Table Company Profile and Development Status of Terumo Heart, Inc (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Terumo Heart, Inc (USA)

    • Figure Sales and Growth Rate Analysis of Terumo Heart, Inc (USA)

    • Figure Revenue and Market Share Analysis of Terumo Heart, Inc (USA)

    • Table Product and Service Introduction of Terumo Heart, Inc (USA)

    • Table Company Profile and Development Status of SynCardia Systems, Inc. (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SynCardia Systems, Inc. (USA)

    • Figure Sales and Growth Rate Analysis of SynCardia Systems, Inc. (USA)

    • Figure Revenue and Market Share Analysis of SynCardia Systems, Inc. (USA)

    • Table Product and Service Introduction of SynCardia Systems, Inc. (USA)

    • Table Company Profile and Development Status of HeartWare International, Inc. (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of HeartWare International, Inc. (USA)

    • Figure Sales and Growth Rate Analysis of HeartWare International, Inc. (USA)

    • Figure Revenue and Market Share Analysis of HeartWare International, Inc. (USA)

    • Table Product and Service Introduction of HeartWare International, Inc. (USA)

    • Table Company Profile and Development Status of Toray Medical Co., Ltd. (Japan)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Toray Medical Co., Ltd. (Japan)

    • Figure Sales and Growth Rate Analysis of Toray Medical Co., Ltd. (Japan)

    • Figure Revenue and Market Share Analysis of Toray Medical Co., Ltd. (Japan)

    • Table Product and Service Introduction of Toray Medical Co., Ltd. (Japan)

    • Table Company Profile and Development Status of Medtronic, Inc. (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medtronic, Inc. (USA)

    • Figure Sales and Growth Rate Analysis of Medtronic, Inc. (USA)

    • Figure Revenue and Market Share Analysis of Medtronic, Inc. (USA)

    • Table Product and Service Introduction of Medtronic, Inc. (USA)

    • Table Company Profile and Development Status of Vital Therapies, Inc. (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vital Therapies, Inc. (USA)

    • Figure Sales and Growth Rate Analysis of Vital Therapies, Inc. (USA)

    • Figure Revenue and Market Share Analysis of Vital Therapies, Inc. (USA)

    • Table Product and Service Introduction of Vital Therapies, Inc. (USA)

    • Table Company Profile and Development Status of Terumo Heart, Inc. (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Terumo Heart, Inc. (USA)

    • Figure Sales and Growth Rate Analysis of Terumo Heart, Inc. (USA)

    • Figure Revenue and Market Share Analysis of Terumo Heart, Inc. (USA)

    • Table Product and Service Introduction of Terumo Heart, Inc. (USA)

    • Table Company Profile and Development Status of Abbott Diabetes Care, Inc (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Diabetes Care, Inc (USA)

    • Figure Sales and Growth Rate Analysis of Abbott Diabetes Care, Inc (USA)

    • Figure Revenue and Market Share Analysis of Abbott Diabetes Care, Inc (USA)

    • Table Product and Service Introduction of Abbott Diabetes Care, Inc (USA)

    • Table Company Profile and Development Status of Asahi Kasei Medical Co., Ltd. (Japan)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Asahi Kasei Medical Co., Ltd. (Japan)

    • Figure Sales and Growth Rate Analysis of Asahi Kasei Medical Co., Ltd. (Japan)

    • Figure Revenue and Market Share Analysis of Asahi Kasei Medical Co., Ltd. (Japan)

    • Table Product and Service Introduction of Asahi Kasei Medical Co., Ltd. (Japan)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US